Previous studies have demonstrated that specific laboratory parameters like alpha-fetoprotein (AFP) and its changes to treatment, inflammatory parameters like C-reactive protein, and etiological factors of HCC like hepatitis B or C have strong correlations with patient response to immunotherapy10–12. This evidence concerns the gene AFP and hepatocellular carcinoma.